Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cryptococcosis].

F Dromer1

  • 1Unité de mycologie Centre national de référence des mycoses humaines et des antifongiques Institut Pasteur 75724 Paris 15. dromer@pasteur.fr

La Revue Du Praticien
|June 5, 2001
PubMed
Summary

Cryptococcus neoformans causes severe infections, particularly meningoencephalitis, in immunocompromised individuals like those with AIDS. Early diagnosis and targeted antifungal therapy, including amphotericin B and fluconazole, are crucial for managing this opportunistic fungal infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Estimating the burden of mucormycosis infections in France (2005-2007) through a capture-recapture method on laboratory and administrative data.

Revue d'epidemiologie et de sante publique·2012
Same author

A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2012
Same author

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
Same author

Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Journal of clinical microbiology·2010
Same author

Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2009

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunology

Context:

  • Cryptococcus neoformans is an encapsulated yeast causing life-threatening infections.
  • Patients with compromised cellular immunity, especially those with Acquired Immunodeficiency Syndrome (AIDS), are at high risk.
  • Disseminated meningoencephalitis is the most common presentation of cryptococcosis, often without acute onset.

Purpose:

  • To outline diagnostic methods for cryptococcosis.
  • To emphasize the importance of identifying secondary infection sites and prognostic factors.
  • To guide appropriate treatment strategies for cryptococcal infections.

Summary:

  • Diagnosis involves India ink staining, polysaccharide antigen detection, culture, and histology.
  • Prognostic factors and additional infection sites must be assessed before treatment.
  • Meningitis treatment requires amphotericin B and 5-fluorocytosine, followed by fluconazole, potentially for lifelong maintenance in immune-deficient patients.

Impact:

  • Improved diagnostic accuracy for cryptococcosis.
  • Optimized treatment selection based on clinical presentation and patient factors.
  • Enhanced patient outcomes through effective and prolonged antifungal therapy, reducing mortality and morbidity.

Related Experiment Videos